Tissue Regeneration Systems Inc., a medical device company developing bioactive implants for bone and soft tissue regeneration, on Thursday announced the close of a $2 million round of financing led by Madison-based Venture Investors and joined by the founders of TRS.
The company is a spin-out of the universities of Michigan and Wisconsin, where TRS’ core proprietary technologies were developed over the past decade, and from which TRS has an exclusive option to commercialize.